|
STRBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.457560E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.012300E-02 |
| Normal-vs-Stage2 |
6.777700E-03 |
| Normal-vs-Stage3 |
6.47280000000139E-05 |
| Normal-vs-Stage4 |
5.634800E-04 |
| Stage1-vs-Stage2 |
1.173170E-01 |
| Stage1-vs-Stage3 |
2.155300E-03 |
| Stage1-vs-Stage4 |
9.519900E-03 |
| Stage2-vs-Stage3 |
5.316000E-01 |
| Stage2-vs-Stage4 |
4.520600E-01 |
| Stage3-vs-Stage4 |
7.448200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.238200E-03 |
| Normal-vs-AfricanAmerican |
9.284200E-02 |
| Normal-vs-Asian |
2.496300E-02 |
| Caucasian-vs-AfricanAmerican |
7.408000E-01 |
| Caucasian-vs-Asian |
7.495000E-01 |
| AfricanAmerican-vs-Asian |
9.350800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.937000E-03 |
| Normal-vs-Female |
2.175100E-03 |
| Male-vs-Female |
8.694400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.261200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.844900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.825100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.567800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.279900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.302550E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.360240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.203400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.425200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.747200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.442790E-01 |
| Classical-VS-Follicular |
4.512000E-02 |
| Classical-VS-Other |
8.046600E-01 |
| Classical-VS-Normal |
5.363600E-03 |
| Tall-VS-Follicular |
6.942400E-03 |
| Tall-VS-Other |
5.975800E-01 |
| Tall-VS-Normal |
4.777800E-04 |
| Follicular-VS-Other |
4.299800E-01 |
| Follicular-VS-Normal |
3.441000E-01 |
| Other-VS-Normal |
1.396620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.635400E-03 |
| Normal-vs-N1 |
5.159400E-04 |
| N0-vs-N1 |
6.354000E-02 |
|
|
